[HTML][HTML] The common gene variants of CYP2C19 affect pharmacokinetics and pharmacodynamics in an active metabolite of clopidogrel in healthy subjects
T Furuta, K Kondo - Journal of Thrombosis and Haemostasis, 2008 - jthjournal.org
Clopidogrel is a thienopyridine derivative with ADP-antagonistic activity and is widely used
for the prevention of ischemic events in patients who have suffered a stroke, non-ST …
for the prevention of ischemic events in patients who have suffered a stroke, non-ST …
[引用][C] The common gene variants of CYP2C19 affect pharmacokinetics and pharmacodynamics in an active metabolite of clopidogrel in healthy subjects
K Umemura, T Furuta, K Kondo - Journal of Thrombosis and …, 2008 - pure.fujita-hu.ac.jp
The common gene variants of CYP2C19 affect pharmacokinetics and pharmacodynamics in
an active metabolite of clopidogrel in healthy subjects — 藤田医科大学 メインナビゲーションに …
an active metabolite of clopidogrel in healthy subjects — 藤田医科大学 メインナビゲーションに …
[引用][C] The common gene variants of CYP2C19 affect pharmacokinetics and pharmacodynamics in an active metabolite of clopidogrel in healthy subjects.
K Umemura, T Furuta, K Kondo - Journal of Thrombosis and …, 2008 - europepmc.org
The common gene variants of CYP2C19 affect pharmacokinetics and pharmacodynamics in
an active metabolite of clopidogrel in healthy subjects. - Abstract - Europe PMC Sign in …
an active metabolite of clopidogrel in healthy subjects. - Abstract - Europe PMC Sign in …
[引用][C] The common gene variants of CYP2C19 affect pharmacokinetics and pharmacodynamics in an active metabolite of clopidogrel in healthy subjects
K Umemura, T Furuta, K Kondo - Journal of thrombosis …, 2008 - pubmed.ncbi.nlm.nih.gov
The common gene variants of CYP2C19 affect pharmacokinetics and pharmacodynamics in
an active metabolite of clopidogrel in healthy subjects The common gene variants of …
an active metabolite of clopidogrel in healthy subjects The common gene variants of …
[引用][C] The common gene variants of CYP2C19 affect pharmacokinetics and pharmacodynamics in an active metabolite of clopidogrel in healthy subjects
K UMEMURA - J Thromb Haemost, 2008 - cir.nii.ac.jp
The common gene variants of CYP2C19 affect pharmacokinetics and pharmacodynamics in
an active metabolite of clopidogrel in healthy subjects | CiNii Research CiNii 国立情報学 …
an active metabolite of clopidogrel in healthy subjects | CiNii Research CiNii 国立情報学 …
[引用][C] The common gene variants of CYP2C19 affect pharmacokinetics and pharmacodynamics in an active metabolite of clopidogrel in healthy subjects
K UMEMURA, T FURUTA… - Journal of Thrombosis and …, 2008 - Wiley Online Library
Clopidogrel is a thienopyridine derivative with ADP-antagonistic activity and is widely used
for the prevention of ischemic events in patients who have suffered a stroke, non-ST …
for the prevention of ischemic events in patients who have suffered a stroke, non-ST …
[引用][C] The common gene variants of CYP2C19 affect pharmacokinetics and pharmacodynamics in an active metabolite of clopidogrel in healthy subjects
K Umemura, T Furuta, K Kondo - Journal of Thrombosis and …, 2008 - pure.fujita-hu.ac.jp
The common gene variants of CYP2C19 affect pharmacokinetics and pharmacodynamics in
an active metabolite of clopidogrel in healthy subjects — Fujita Health University Skip to main …
an active metabolite of clopidogrel in healthy subjects — Fujita Health University Skip to main …
[引用][C] The common gene variants of CYP2C19 affect pharmacokinetics and pharmacodynamics in an active metabolite of clopidogrel in healthy subjects
K UMEMURA, T FURUTA, K KONDO - Journal of Thrombosis and …, 2008 - cir.nii.ac.jp
The common gene variants of CYP2C19 affect pharmacokinetics and pharmacodynamics in an
active metabolite of clopidogrel in healthy subjects | CiNii Research CiNii 国立情報学研究所 …
active metabolite of clopidogrel in healthy subjects | CiNii Research CiNii 国立情報学研究所 …